Barely Significant
← all excerpts

Comparative Genomic Analysis of Key Oncogenic Pathways in Hepatocellular Carcinoma Among Diverse Populations.

Cancers (Basel) · 2025 · PMC12025884 · PMID 40282485

7
hedged sentences
0.0700
closest p · 1.4× alpha
0.1087
boldest claim

The sentences

borderline significancep = 0.07so close (0.05 < p ≤ 0.1)
Additionally, IGF1R mutations exhibited borderline significance (7.2% vs. 2.9%, p = 0.07).

also in 2,536 other papers

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)
Kaplan–Meier plots were utilized to explore survival differences related to PI3K pathway alterations in NHW HCC patients and showed a trend toward poorer overall survival, though it did not reach statistical significance ( p = 0.09) ( Figure S1 ).

also in 23,610 other papers

did not reach statistical significancep = 0.1087not close (p > 0.1)
The median mutation count was slightly lower in the H/L cohort (six mutations, IQR: 4–46) compared to the NHW cohort (eight mutations, IQR: 4–50), though this difference did not reach statistical significance ( p = 0.1087).

also in 53,799 other papers

marginal significanceno p-value reported
All p -values are reported to ensure transparency, and findings with marginal significance were interpreted cautiously.

also in 2,005 other papers

borderline significantno p-value reported
To better characterize the biological relevance of pathway-specific alterations, we examined the nature of somatic mutations in genes that showed statistically significant or borderline significant differences between H/L and NHW patients.

also in 3,616 other papers

a slight trendno p-value reported
The WNT-altered group (red curve) exhibited a slight trend toward reduced survival compared to the non-altered group (blue curve), but the overlapping survival curves and wide confidence intervals suggest substantial variability in survival estimates.

also in 1,563 other papers

a possible trendno p-value reported
Notably, ERBB4 mutations were observed in 5.8% of H/L patients compared to 2.3% of NHW patients ( p = 0.1077), and IGF1R mutations were detected in 7.2% of H/L patients versus 2.9% of NHW patients ( p = 0.07798), indicating a possible trend toward increased RTK pathway activation in H/L patients.

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.